United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Technology Industry News Tata Elxsi delivers steady growth in Q1 FY’25 amidst expanding technology frontiers Tata Elxsi, recognized globally for its design-led technology services, has reported a promising start to the financial year… byPallavi MadhirajuJuly 10, 2024